跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,640 条关于
“Trk”
全部
1,640
临床试验
1,070
药物
434
机构
32
资讯
104
去年
Next-Generation TRK Inhibitors Show Promise in Treating NTRK Fusion-Positive Cancers
去年
Larotrectinib Shows High Efficacy in Pediatric Solid Tumors with NTRK Fusion
3个月前
Vcare PharmaTech's Next-Generation TRK Inhibitor Eratrectinib Wins NMPA Approval for NTRK Fusion-Positive Solid Tumors
9个月前
InnoCare's Next-Generation TRK Inhibitor Zurletrectinib Receives NMPA Approval in China for NTRK Fusion-Positive Solid Tumors
10个月前
InnoCare's Zurletrectinib Shows 90% Response Rate in Pediatric NTRK-Fusion Solid Tumors
去年
InnoCare Presents Promising Clinical Data for Multiple Oncology Pipeline Candidates at Major Medical Conferences
去年
Cullgen Completes Phase 1 Enrollment for Novel Non-Opioid Pain Therapy CG001419
去年
Nuvalent to Present Pivotal Data for ROS1-Selective Inhibitor Zidesamtinib in Advanced Lung Cancer
去年
EMA Recommends Repotrectinib for Advanced ROS1-Positive Non-Small Cell Lung Cancer
去年
Nuvalent to Present First Clinical Data for Next-Generation ALK Inhibitor NVL-655 at AACR-NCI-EORTC Symposium
第 1 页,共 11 页
上一页
下一页